Health Condition 1: R688- Other general symptoms and signs
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: postmenopausal females aged 50-70 years, diagnosed with osteoporosis as per World Health Organization (WHO) criteria, (BMD that lies - 2.5 standard deviation or more below the average value for young healthy women
Exclusion criteria
Exclusion criteria: woman suffering from secondary osteoporosis such as inflammatory joint or bowel disorders, current glucocorticoid therapy, chronic kidney disease, malabsorption, untreated endocrine disorders
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Change in Bone Mineral Density (BMD) at the lumbar spine, femoral neck, and total hip measured using Dual-Energy X-ray Absorptiometry (DEXA). Timepoint: Baseline (Week 0) Before starting the intervention At 24 Weeks (End of Treatment) After completion of the 6-month intervention | — |
Secondary
| Measure | Time frame |
|---|---|
| This research is designed to provide tailored insights into the potential of Ayurveda formulations for enhancing bone health in menopausal & geriatric females. Positive outcomes could lead to targeted interventions that address the specific needs of these populations, improving their overall quality of life & reducing the burden of osteoporosis- related complications.Timepoint: Time Points Baseline, 12 Weeks (Mid of Treatment), 24 Weeks (End of Treatment). | — |
Countries
India
Contacts
AIIMS, Delhi